Rosiglitazone 英文名称: Rosiglitazone | ||||||||||||||||||||||||||||||||||||||||||||||
型号:null 产品货号: INR1302-0005MG | ||||||||||||||||||||||||||||||||||||||||||||||
价格:请致电:010-57128832,18610462672 | ||||||||||||||||||||||||||||||||||||||||||||||
品牌: gene operation | ||||||||||||||||||||||||||||||||||||||||||||||
INR1302-Rosiglitazone Rosiglitazone,≥98% 【英文同义名】:ROZ,BRL 49653 【中文同义名】:罗格列*** 订购信息:(原装进口,常备现货)
产品描述Rosiglitazone 是一种***活性的高亲和力PPARγ激动剂 [1]。Rosiglitazone同时激活含有α1-和α2-的AMPK复合物,并显著增加的乙酰-CoA羧化酶的***酸化[1]。Rosiglitazone通过激活核受体PPAR-γ提高胰岛素的敏感性,但体外实验证明Rosiglitazone 激活的PPAR-gamma2为小鼠骨髓成骨细胞抑制剂,体内实验也证明Rosiglitazone能导致显著骨质流失[2]。在3T3-L1脂肪细胞中,Rosiglitazone改变线粒体的形态学特征和蛋白质图谱[3]。 靶点
化学特性
储存液配制
结构式使用浓度(仅作参考)Rosiglitazone的具体使用浓度请参考相关文献,并根据自身实验条件(如实验目的,细胞种类,培养特性等)进行摸索和优化。 参考文献[1] Fryer LG, et al. The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem. 2002 Jul 12;277(28):25226-32. Epub 2002 May 6. [2] Rzonca SO, et al. Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology. 2004 Jan; 145(1):401-6. Epub 2003 Sep 18. [3] Wilson-Fritch L, et al. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest. 2004 Nov;114(9):1281-9. |